

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.11391428 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.82806755 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.82806755 |
| 4 | ribosomal small subunit assembly (GO:0000028) | 4.53182558 |
| 5 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.51344961 |
| 6 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.47753829 |
| 7 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.46382932 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 4.36000585 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 4.36000585 |
| 10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.36000585 |
| 11 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.36000585 |
| 12 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.36000585 |
| 13 | modulation by symbiont of host immune response (GO:0052553) | 4.36000585 |
| 14 | positive regulation of B cell differentiation (GO:0045579) | 4.34371233 |
| 15 | valine metabolic process (GO:0006573) | 4.32523189 |
| 16 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.32348313 |
| 17 | positive regulation of prostaglandin secretion (GO:0032308) | 4.31393674 |
| 18 | regulation of gamma-delta T cell activation (GO:0046643) | 4.26106487 |
| 19 | protein maturation by protein folding (GO:0022417) | 4.26047433 |
| 20 | COPI coating of Golgi vesicle (GO:0048205) | 4.17350888 |
| 21 | Golgi transport vesicle coating (GO:0048200) | 4.17350888 |
| 22 | protein localization to endosome (GO:0036010) | 4.00097531 |
| 23 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.99022076 |
| 24 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.92981757 |
| 25 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.92387518 |
| 26 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.88451762 |
| 27 | definitive hemopoiesis (GO:0060216) | 3.83335305 |
| 28 | neutrophil activation involved in immune response (GO:0002283) | 3.78734834 |
| 29 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.75657013 |
| 30 | regulation of prostaglandin secretion (GO:0032306) | 3.72529724 |
| 31 | regulation of chronic inflammatory response (GO:0002676) | 3.71467701 |
| 32 | negative regulation of phagocytosis (GO:0050765) | 3.68967477 |
| 33 | regulation of podosome assembly (GO:0071801) | 3.66889538 |
| 34 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.57257909 |
| 35 | regulation of vitamin metabolic process (GO:0030656) | 3.54835551 |
| 36 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.53291073 |
| 37 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.51104354 |
| 38 | nuclear envelope reassembly (GO:0031468) | 3.47495622 |
| 39 | mitotic nuclear envelope reassembly (GO:0007084) | 3.47495622 |
| 40 | low-density lipoprotein particle clearance (GO:0034383) | 3.46794549 |
| 41 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.45142639 |
| 42 | Peyers patch development (GO:0048541) | 3.45142639 |
| 43 | protein retention in ER lumen (GO:0006621) | 3.44526011 |
| 44 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.42218577 |
| 45 | skin morphogenesis (GO:0043589) | 3.37950807 |
| 46 | activation of MAPKKK activity (GO:0000185) | 3.36837107 |
| 47 | interleukin-1-mediated signaling pathway (GO:0070498) | 3.35818548 |
| 48 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.35426911 |
| 49 | positive regulation of icosanoid secretion (GO:0032305) | 3.34639491 |
| 50 | eosinophil chemotaxis (GO:0048245) | 3.33030200 |
| 51 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 3.29140326 |
| 52 | myeloid dendritic cell activation (GO:0001773) | 3.28602675 |
| 53 | barbed-end actin filament capping (GO:0051016) | 3.26353777 |
| 54 | activation of Rac GTPase activity (GO:0032863) | 3.26111883 |
| 55 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.21782711 |
| 56 | natural killer cell differentiation (GO:0001779) | 3.19562365 |
| 57 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.19322078 |
| 58 | response to host (GO:0075136) | 3.19322078 |
| 59 | response to host defenses (GO:0052200) | 3.19322078 |
| 60 | DNA unwinding involved in DNA replication (GO:0006268) | 3.18439171 |
| 61 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.18318077 |
| 62 | glycosphingolipid catabolic process (GO:0046479) | 3.17623095 |
| 63 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.17393705 |
| 64 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.16855584 |
| 65 | regulation of B cell differentiation (GO:0045577) | 3.16532969 |
| 66 | myeloid dendritic cell differentiation (GO:0043011) | 3.15731500 |
| 67 | oligosaccharide catabolic process (GO:0009313) | 3.15286329 |
| 68 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 3.12502444 |
| 69 | positive regulation of macrophage activation (GO:0043032) | 3.10452506 |
| 70 | T cell homeostasis (GO:0043029) | 3.10092619 |
| 71 | cellular response to arsenic-containing substance (GO:0071243) | 3.09645039 |
| 72 | regulation of mononuclear cell migration (GO:0071675) | 3.07849010 |
| 73 | positive regulation of antigen processing and presentation (GO:0002579) | 3.07804256 |
| 74 | mature B cell differentiation involved in immune response (GO:0002313) | 3.07796127 |
| 75 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 3.07552209 |
| 76 | rhodopsin mediated signaling pathway (GO:0016056) | 3.07179845 |
| 77 | myeloid cell activation involved in immune response (GO:0002275) | 3.03486730 |
| 78 | response to muramyl dipeptide (GO:0032495) | 3.03004707 |
| 79 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.02217554 |
| 80 | regulation of chemokine biosynthetic process (GO:0045073) | 2.99730636 |
| 81 | regulation of cholesterol storage (GO:0010885) | 2.98378220 |
| 82 | B cell receptor signaling pathway (GO:0050853) | 2.97916551 |
| 83 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.97063190 |
| 84 | establishment of viral latency (GO:0019043) | 2.96671528 |
| 85 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.95435228 |
| 86 | respiratory burst (GO:0045730) | 2.94674226 |
| 87 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.94157900 |
| 88 | ncRNA 3-end processing (GO:0043628) | 2.93798769 |
| 89 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.90672097 |
| 90 | eosinophil migration (GO:0072677) | 2.89709164 |
| 91 | regulation of natural killer cell differentiation (GO:0032823) | 2.88777231 |
| 92 | megakaryocyte development (GO:0035855) | 2.88747961 |
| 93 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.88463633 |
| 94 | neutrophil activation (GO:0042119) | 2.88211640 |
| 95 | membrane raft organization (GO:0031579) | 2.87443062 |
| 96 | granulocyte activation (GO:0036230) | 2.85537095 |
| 97 | macrophage activation involved in immune response (GO:0002281) | 2.85268869 |
| 98 | pyrimidine nucleoside salvage (GO:0043097) | 2.84482393 |
| 99 | pyrimidine-containing compound salvage (GO:0008655) | 2.84482393 |
| 100 | neutrophil mediated immunity (GO:0002446) | 2.81699482 |
| 101 | regulation of icosanoid secretion (GO:0032303) | 2.81361531 |
| 102 | regulation of superoxide anion generation (GO:0032928) | 2.80313910 |
| 103 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.80264416 |
| 104 | cell adhesion mediated by integrin (GO:0033627) | 2.79597471 |
| 105 | cellular copper ion homeostasis (GO:0006878) | 2.79515234 |
| 106 | regulation of erythrocyte differentiation (GO:0045646) | 2.79254176 |
| 107 | response to peptidoglycan (GO:0032494) | 2.79126414 |
| 108 | mast cell activation (GO:0045576) | 2.78679775 |
| 109 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.78558128 |
| 110 | response to interferon-beta (GO:0035456) | 2.78183131 |
| 111 | dendritic cell differentiation (GO:0097028) | 2.77927991 |
| 112 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.77671127 |
| 113 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.76813722 |
| 114 | mature B cell differentiation (GO:0002335) | 2.76745309 |
| 115 | glycolipid catabolic process (GO:0019377) | 2.76267399 |
| 116 | response to progesterone (GO:0032570) | 2.74166169 |
| 117 | mitotic sister chromatid cohesion (GO:0007064) | 2.73398290 |
| 118 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.73072346 |
| 119 | leukocyte degranulation (GO:0043299) | 2.71999478 |
| 120 | NIK/NF-kappaB signaling (GO:0038061) | 2.71961994 |
| 121 | positive regulation of fatty acid transport (GO:2000193) | 2.70847863 |
| 122 | hemidesmosome assembly (GO:0031581) | 2.69692434 |
| 123 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.66337141 |
| 124 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.65592068 |
| 125 | positive regulation of natural killer cell activation (GO:0032816) | 2.64419120 |
| 126 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.61831456 |
| 127 | macrophage chemotaxis (GO:0048246) | 2.61251000 |
| 128 | leukocyte homeostasis (GO:0001776) | 2.60420814 |
| 129 | pinocytosis (GO:0006907) | 2.60011174 |
| 130 | lymphocyte homeostasis (GO:0002260) | 2.59641432 |
| 131 | response to host immune response (GO:0052572) | 2.58860004 |
| 132 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.58860004 |
| 133 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.58710490 |
| 134 | regulation of cholesterol homeostasis (GO:2000188) | 2.58618964 |
| 135 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.58437418 |
| 136 | regulation of immunoglobulin secretion (GO:0051023) | 2.56430710 |
| 137 | positive regulation of interleukin-17 production (GO:0032740) | 2.55303556 |
| 138 | diaphragm development (GO:0060539) | 2.55074152 |
| 139 | monocyte chemotaxis (GO:0002548) | 2.54883588 |
| 140 | cellular response to virus (GO:0098586) | 2.54002914 |
| 141 | negative regulation of cell killing (GO:0031342) | 2.53844471 |
| 142 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.53844471 |
| 143 | positive regulation of interleukin-1 beta production (GO:0032731) | 2.53651837 |
| 144 | establishment of integrated proviral latency (GO:0075713) | 2.53453037 |
| 145 | nucleotide salvage (GO:0043173) | 2.52380617 |
| 146 | negative regulation of interleukin-12 production (GO:0032695) | 2.52349467 |
| 147 | modulation by symbiont of host cellular process (GO:0044068) | 2.51817936 |
| 148 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.51803606 |
| 149 | B cell mediated immunity (GO:0019724) | 2.50240866 |
| 150 | negative regulation of viral release from host cell (GO:1902187) | 2.49684699 |
| 151 | lymph node development (GO:0048535) | 2.48824246 |
| 152 | decidualization (GO:0046697) | 2.48507433 |
| 153 | purine nucleotide salvage (GO:0032261) | 2.48216193 |
| 154 | glycolytic process (GO:0006096) | 2.48029304 |
| 155 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.47482654 |
| 156 | response to protozoan (GO:0001562) | 2.47376635 |
| 157 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.47362629 |
| 158 | fibrinolysis (GO:0042730) | 2.47220495 |
| 159 | establishment of endothelial barrier (GO:0061028) | 2.46521628 |
| 160 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.45938827 |
| 161 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.45755584 |
| 162 | myeloid leukocyte activation (GO:0002274) | 2.45280064 |
| 163 | GMP metabolic process (GO:0046037) | 2.45182794 |
| 164 | negative regulation of lipid storage (GO:0010888) | 2.44070781 |
| 165 | tRNA methylation (GO:0030488) | 2.43997871 |
| 166 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.43976916 |
| 167 | natural killer cell mediated immunity (GO:0002228) | 2.43976916 |
| 168 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.43646078 |
| 169 | cellular response to nicotine (GO:0071316) | 2.43446407 |
| 170 | positive regulation of B cell activation (GO:0050871) | 2.43276452 |
| 171 | regulation of antigen processing and presentation (GO:0002577) | 2.43230802 |
| 172 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.42356527 |
| 173 | maturation of SSU-rRNA (GO:0030490) | 2.41931739 |
| 174 | regulation of necrotic cell death (GO:0010939) | 2.40539380 |
| 175 | regulation of interleukin-17 production (GO:0032660) | 2.40311228 |
| 176 | positive regulation of interferon-alpha production (GO:0032727) | 2.40175213 |
| 177 | mesodermal cell differentiation (GO:0048333) | 2.37866190 |
| 178 | glucose catabolic process (GO:0006007) | 2.37578709 |
| 179 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.36503879 |
| 180 | substrate-dependent cell migration (GO:0006929) | 2.36484442 |
| 181 | sphingosine metabolic process (GO:0006670) | 2.36226349 |
| 182 | response to type I interferon (GO:0034340) | 2.35696411 |
| 183 | glucose 6-phosphate metabolic process (GO:0051156) | 2.35679725 |
| 184 | type I interferon signaling pathway (GO:0060337) | 2.35134112 |
| 185 | cellular response to type I interferon (GO:0071357) | 2.35134112 |
| 186 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.34367772 |
| 187 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.34111225 |
| 188 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.33967099 |
| 189 | mitotic chromosome condensation (GO:0007076) | 2.33236242 |
| 190 | endothelial cell chemotaxis (GO:0035767) | 2.31044091 |
| 191 | negative regulation of ERBB signaling pathway (GO:1901185) | 2.30421974 |
| 192 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.29686429 |
| 193 | cellular protein complex localization (GO:0034629) | 2.28637076 |
| 194 | T-helper 1 type immune response (GO:0042088) | 2.28304680 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.00883020 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.74519011 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.71686395 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.57205404 |
| 5 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.52942282 |
| 6 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.42331108 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.36255804 |
| 8 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.34184952 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 3.32114981 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.21110638 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.70840836 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.67876921 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.64008376 |
| 14 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.53142421 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.50229935 |
| 16 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.47414362 |
| 17 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.45088258 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.43761540 |
| 19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.42462549 |
| 20 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.42163060 |
| 21 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.39754287 |
| 22 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.37787963 |
| 23 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.36993739 |
| 24 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.35419524 |
| 25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.28761556 |
| 26 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.28688002 |
| 27 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.20893804 |
| 28 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.19757202 |
| 29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.16855070 |
| 30 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 2.15759241 |
| 31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.13982520 |
| 32 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.03085680 |
| 33 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00409543 |
| 34 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.95728850 |
| 35 | UTX_26944678_Chip-Seq_JUKART_Human | 1.94352007 |
| 36 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.92287344 |
| 37 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.87857197 |
| 38 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.87067432 |
| 39 | GATA1_22025678_ChIP-Seq_K562_Human | 1.87040574 |
| 40 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.84604360 |
| 41 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.83039725 |
| 42 | MAF_26560356_Chip-Seq_TH1_Human | 1.77943274 |
| 43 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.76156399 |
| 44 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.74052640 |
| 45 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.73857234 |
| 46 | * MYB_26560356_Chip-Seq_TH2_Human | 1.72779958 |
| 47 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.71157133 |
| 48 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.70869613 |
| 49 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.69881318 |
| 50 | SPI1_23127762_ChIP-Seq_K562_Human | 1.66437353 |
| 51 | ATF3_27146783_Chip-Seq_COLON_Human | 1.66008470 |
| 52 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.65654749 |
| 53 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65444051 |
| 54 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65405341 |
| 55 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.63994648 |
| 56 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.63837790 |
| 57 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.63334406 |
| 58 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.59011378 |
| 59 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.58458051 |
| 60 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.56063652 |
| 61 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.56044117 |
| 62 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.54362587 |
| 63 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53721838 |
| 64 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.53271252 |
| 65 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.53110131 |
| 66 | MYB_26560356_Chip-Seq_TH1_Human | 1.52685649 |
| 67 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.52550202 |
| 68 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.51649139 |
| 69 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.51147174 |
| 70 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.47944716 |
| 71 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.45898390 |
| 72 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.44670126 |
| 73 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.44088387 |
| 74 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.41606885 |
| 75 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.40202202 |
| 76 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.40199781 |
| 77 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39785794 |
| 78 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.38680476 |
| 79 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.38672896 |
| 80 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.38148451 |
| 81 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.37276152 |
| 82 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.37068670 |
| 83 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.36245190 |
| 84 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36048994 |
| 85 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.35951100 |
| 86 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.32116587 |
| 87 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.31374696 |
| 88 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.30633477 |
| 89 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28787473 |
| 90 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.28397321 |
| 91 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.27555720 |
| 92 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.25423448 |
| 93 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25051423 |
| 94 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.24345909 |
| 95 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.23998209 |
| 96 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.23974094 |
| 97 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.23903086 |
| 98 | MAF_26560356_Chip-Seq_TH2_Human | 1.23765124 |
| 99 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.23141950 |
| 100 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.22958379 |
| 101 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.22911236 |
| 102 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.21691126 |
| 103 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.20776697 |
| 104 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.20776697 |
| 105 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.20250726 |
| 106 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.17721978 |
| 107 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.16950672 |
| 108 | P68_20966046_ChIP-Seq_HELA_Human | 1.16770227 |
| 109 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.16313223 |
| 110 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.14843253 |
| 111 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.14384868 |
| 112 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.13475032 |
| 113 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.13033660 |
| 114 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.12849613 |
| 115 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.11140779 |
| 116 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.11075537 |
| 117 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.11069884 |
| 118 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.10362767 |
| 119 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.09399937 |
| 120 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.08662310 |
| 121 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.08439837 |
| 122 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.08430383 |
| 123 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.07938764 |
| 124 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.07065943 |
| 125 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.06149154 |
| 126 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.05897801 |
| 127 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.05532539 |
| 128 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04090028 |
| 129 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.02620656 |
| 130 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.01775818 |
| 131 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.01357922 |
| 132 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.01024892 |
| 133 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.00478537 |
| 134 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00414291 |
| 135 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.99267961 |
| 136 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.98687456 |
| 137 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 0.98255010 |
| 138 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97898751 |
| 139 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.97874291 |
| 140 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.97452717 |
| 141 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.96862165 |
| 142 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.96791595 |
| 143 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.96754601 |
| 144 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96278684 |
| 145 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.95226111 |
| 146 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94041602 |
| 147 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.91896228 |
| 148 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.91752421 |
| 149 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90554521 |
| 150 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.88489805 |
| 151 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.86482582 |
| 152 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85721697 |
| 153 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.80376326 |
| 154 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.79725247 |
| 155 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.78718866 |
| 156 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.77429144 |
| 157 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.75926809 |
| 158 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.74712004 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009278_abnormal_bone_marrow | 4.35890130 |
| 2 | MP0005451_abnormal_body_composition | 3.25299445 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.14792330 |
| 4 | MP0003300_gastrointestinal_ulcer | 2.89459415 |
| 5 | MP0005397_hematopoietic_system_phenotyp | 2.82300465 |
| 6 | MP0001545_abnormal_hematopoietic_system | 2.82300465 |
| 7 | MP0000685_abnormal_immune_system | 2.80558414 |
| 8 | MP0003436_decreased_susceptibility_to | 2.78999541 |
| 9 | MP0004808_abnormal_hematopoietic_stem | 2.53481723 |
| 10 | MP0003303_peritoneal_inflammation | 2.42180807 |
| 11 | MP0002419_abnormal_innate_immunity | 2.37623113 |
| 12 | MP0000465_gastrointestinal_hemorrhage | 2.36202179 |
| 13 | MP0009785_altered_susceptibility_to | 2.28257564 |
| 14 | MP0001873_stomach_inflammation | 2.25759029 |
| 15 | MP0005025_abnormal_response_to | 2.24678807 |
| 16 | MP0001800_abnormal_humoral_immune | 2.23143032 |
| 17 | MP0005464_abnormal_platelet_physiology | 2.22019744 |
| 18 | MP0002396_abnormal_hematopoietic_system | 2.21589881 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.19965282 |
| 20 | MP0005076_abnormal_cell_differentiation | 2.17117741 |
| 21 | MP0002723_abnormal_immune_serum | 2.08732304 |
| 22 | MP0003806_abnormal_nucleotide_metabolis | 2.04492127 |
| 23 | MP0001819_abnormal_immune_cell | 2.04371601 |
| 24 | MP0002420_abnormal_adaptive_immunity | 2.03673450 |
| 25 | MP0005671_abnormal_response_to | 2.03654897 |
| 26 | MP0005257_abnormal_intraocular_pressure | 2.03518176 |
| 27 | MP0002398_abnormal_bone_marrow | 2.01812922 |
| 28 | MP0010155_abnormal_intestine_physiology | 2.01486794 |
| 29 | MP0005000_abnormal_immune_tolerance | 2.01316948 |
| 30 | MP0009333_abnormal_splenocyte_physiolog | 1.99909952 |
| 31 | MP0010234_abnormal_vibrissa_follicle | 1.97787698 |
| 32 | MP0002332_abnormal_exercise_endurance | 1.90634088 |
| 33 | MP0000689_abnormal_spleen_morphology | 1.84905673 |
| 34 | MP0010307_abnormal_tumor_latency | 1.82139038 |
| 35 | MP0005387_immune_system_phenotype | 1.81130001 |
| 36 | MP0001790_abnormal_immune_system | 1.81130001 |
| 37 | MP0003011_delayed_dark_adaptation | 1.77435516 |
| 38 | MP0002722_abnormal_immune_system | 1.77023223 |
| 39 | MP0002148_abnormal_hypersensitivity_rea | 1.73806160 |
| 40 | MP0005058_abnormal_lysosome_morphology | 1.72337394 |
| 41 | MP0000716_abnormal_immune_system | 1.71156580 |
| 42 | MP0003763_abnormal_thymus_physiology | 1.70416838 |
| 43 | MP0004185_abnormal_adipocyte_glucose | 1.68293928 |
| 44 | MP0000566_synostosis | 1.66831653 |
| 45 | MP0002405_respiratory_system_inflammati | 1.66269579 |
| 46 | MP0000490_abnormal_crypts_of | 1.64854186 |
| 47 | MP0003693_abnormal_embryo_hatching | 1.64449305 |
| 48 | MP0005551_abnormal_eye_electrophysiolog | 1.62954555 |
| 49 | MP0000703_abnormal_thymus_morphology | 1.62886042 |
| 50 | MP0002796_impaired_skin_barrier | 1.62784492 |
| 51 | MP0003123_paternal_imprinting | 1.59348521 |
| 52 | MP0001845_abnormal_inflammatory_respons | 1.58479234 |
| 53 | MP0005165_increased_susceptibility_to | 1.57062309 |
| 54 | MP0002166_altered_tumor_susceptibility | 1.56706091 |
| 55 | MP0002429_abnormal_blood_cell | 1.55644799 |
| 56 | MP0000569_abnormal_digit_pigmentation | 1.55604291 |
| 57 | MP0004947_skin_inflammation | 1.53397212 |
| 58 | MP0003866_abnormal_defecation | 1.53198929 |
| 59 | MP0008260_abnormal_autophagy | 1.53117232 |
| 60 | MP0005166_decreased_susceptibility_to | 1.52345435 |
| 61 | MP0009764_decreased_sensitivity_to | 1.51561368 |
| 62 | MP0000858_altered_metastatic_potential | 1.49997166 |
| 63 | MP0005501_abnormal_skin_physiology | 1.49538252 |
| 64 | MP0003448_altered_tumor_morphology | 1.48291342 |
| 65 | MP0003172_abnormal_lysosome_physiology | 1.48003898 |
| 66 | MP0010352_gastrointestinal_tract_polyps | 1.47556663 |
| 67 | MP0003329_amyloid_beta_deposits | 1.46261062 |
| 68 | MP0001853_heart_inflammation | 1.45184160 |
| 69 | MP0004233_abnormal_muscle_weight | 1.43112939 |
| 70 | MP0002139_abnormal_hepatobiliary_system | 1.40722942 |
| 71 | MP0004510_myositis | 1.38904741 |
| 72 | MP0001216_abnormal_epidermal_layer | 1.34949953 |
| 73 | MP0009840_abnormal_foam_cell | 1.34295914 |
| 74 | MP0003705_abnormal_hypodermis_morpholog | 1.34200850 |
| 75 | MP0003656_abnormal_erythrocyte_physiolo | 1.33219633 |
| 76 | MP0001533_abnormal_skeleton_physiology | 1.32374378 |
| 77 | MP0001849_ear_inflammation | 1.32154474 |
| 78 | MP0002877_abnormal_melanocyte_morpholog | 1.32139368 |
| 79 | MP0003191_abnormal_cellular_cholesterol | 1.31930094 |
| 80 | MP0003566_abnormal_cell_adhesion | 1.31619326 |
| 81 | MP0004858_abnormal_nervous_system | 1.30336570 |
| 82 | MP0005174_abnormal_tail_pigmentation | 1.28909645 |
| 83 | MP0005253_abnormal_eye_physiology | 1.28680949 |
| 84 | MP0006082_CNS_inflammation | 1.27901064 |
| 85 | MP0002006_tumorigenesis | 1.27714507 |
| 86 | MP0005023_abnormal_wound_healing | 1.23525510 |
| 87 | MP0008057_abnormal_DNA_replication | 1.21889723 |
| 88 | MP0003091_abnormal_cell_migration | 1.21159718 |
| 89 | MP0005666_abnormal_adipose_tissue | 1.19423278 |
| 90 | MP0003077_abnormal_cell_cycle | 1.16422422 |
| 91 | MP0003724_increased_susceptibility_to | 1.16109321 |
| 92 | MP0002060_abnormal_skin_morphology | 1.09059412 |
| 93 | MP0002019_abnormal_tumor_incidence | 1.08942438 |
| 94 | MP0001764_abnormal_homeostasis | 1.08360993 |
| 95 | MP0008469_abnormal_protein_level | 1.08346809 |
| 96 | MP0001851_eye_inflammation | 1.08091497 |
| 97 | MP0005310_abnormal_salivary_gland | 1.05833840 |
| 98 | MP0000751_myopathy | 1.01472864 |
| 99 | MP0003315_abnormal_perineum_morphology | 1.00315302 |
| 100 | MP0000343_altered_response_to | 0.99551632 |
| 101 | MP0000750_abnormal_muscle_regeneration | 0.98833962 |
| 102 | MP0001915_intracranial_hemorrhage | 0.96257659 |
| 103 | MP0002933_joint_inflammation | 0.95210393 |
| 104 | MP0006072_abnormal_retinal_apoptosis | 0.94642422 |
| 105 | MP0005375_adipose_tissue_phenotype | 0.94605025 |
| 106 | MP0005167_abnormal_blood-brain_barrier | 0.91916249 |
| 107 | MP0000678_abnormal_parathyroid_gland | 0.90573110 |
| 108 | MP0005164_abnormal_response_to | 0.90291263 |
| 109 | MP0002254_reproductive_system_inflammat | 0.89408711 |
| 110 | MP0005197_abnormal_uvea_morphology | 0.87688947 |
| 111 | MP0000358_abnormal_cell_content/ | 0.87511093 |
| 112 | MP0000313_abnormal_cell_death | 0.87162719 |
| 113 | MP0004883_abnormal_blood_vessel | 0.85622907 |
| 114 | MP0001663_abnormal_digestive_system | 0.84286893 |
| 115 | MP0000749_muscle_degeneration | 0.83066912 |
| 116 | MP0001324_abnormal_eye_pigmentation | 0.82826963 |
| 117 | MP0003111_abnormal_nucleus_morphology | 0.80645330 |
| 118 | MP0005330_cardiomyopathy | 0.79682012 |
| 119 | MP0010094_abnormal_chromosome_stability | 0.79376856 |
| 120 | MP0000604_amyloidosis | 0.79344800 |
| 121 | MP0005670_abnormal_white_adipose | 0.78554190 |
| 122 | MP0003950_abnormal_plasma_membrane | 0.78418134 |
| 123 | MP0000467_abnormal_esophagus_morphology | 0.76270147 |
| 124 | MP0001986_abnormal_taste_sensitivity | 0.75312056 |
| 125 | MP0000579_abnormal_nail_morphology | 0.74916534 |
| 126 | MP0010678_abnormal_skin_adnexa | 0.74043523 |
| 127 | MP0003075_altered_response_to | 0.72915915 |
| 128 | MP0002998_abnormal_bone_remodeling | 0.72718186 |
| 129 | MP0000733_abnormal_muscle_development | 0.71421495 |
| 130 | MP0004272_abnormal_basement_membrane | 0.71263464 |
| 131 | MP0000537_abnormal_urethra_morphology | 0.70477636 |
| 132 | MP0000003_abnormal_adipose_tissue | 0.69486278 |
| 133 | MP0004264_abnormal_extraembryonic_tissu | 0.68498139 |
| 134 | MP0010771_integument_phenotype | 0.68420684 |
| 135 | MP0005391_vision/eye_phenotype | 0.67360630 |
| 136 | MP0008007_abnormal_cellular_replicative | 0.67331898 |
| 137 | MP0004957_abnormal_blastocyst_morpholog | 0.67283468 |
| 138 | MP0000747_muscle_weakness | 0.66651700 |
| 139 | MP0005390_skeleton_phenotype | 0.66478483 |
| 140 | MP0000383_abnormal_hair_follicle | 0.66217561 |
| 141 | MP0000350_abnormal_cell_proliferation | 0.65109932 |
| 142 | MP0003453_abnormal_keratinocyte_physiol | 0.65035196 |
| 143 | MP0008004_abnormal_stomach_pH | 0.64614042 |
| 144 | MP0003828_pulmonary_edema | 0.63918122 |
| 145 | MP0005621_abnormal_cell_physiology | 0.62229627 |
| 146 | MP0005195_abnormal_posterior_eye | 0.61821089 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital stationary night blindness (HP:0007642) | 5.29733746 |
| 2 | Abnormality of glycolipid metabolism (HP:0010969) | 5.22636943 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.22636943 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.22636943 |
| 5 | Thrombocytosis (HP:0001894) | 4.87416406 |
| 6 | Interstitial pulmonary disease (HP:0006530) | 4.69128892 |
| 7 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 4.62990277 |
| 8 | Bony spicule pigmentary retinopathy (HP:0007737) | 4.43023074 |
| 9 | Recurrent abscess formation (HP:0002722) | 4.34837439 |
| 10 | Abnormal rod and cone electroretinograms (HP:0008323) | 4.31130060 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 4.18909049 |
| 12 | Axonal loss (HP:0003447) | 4.12399082 |
| 13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.99363330 |
| 14 | Pendular nystagmus (HP:0012043) | 3.92746707 |
| 15 | Eczematoid dermatitis (HP:0000976) | 3.77489698 |
| 16 | Pigmentary retinal degeneration (HP:0001146) | 3.70880382 |
| 17 | Vacuolated lymphocytes (HP:0001922) | 3.63532789 |
| 18 | Nuclear cataract (HP:0100018) | 3.61990551 |
| 19 | Cellulitis (HP:0100658) | 3.47414466 |
| 20 | Myositis (HP:0100614) | 3.45218112 |
| 21 | Chorioretinal atrophy (HP:0000533) | 3.34123274 |
| 22 | Neurofibrillary tangles (HP:0002185) | 3.29572375 |
| 23 | Vertebral compression fractures (HP:0002953) | 3.28001820 |
| 24 | Loss of speech (HP:0002371) | 3.20547693 |
| 25 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.18649364 |
| 26 | Abnormal platelet function (HP:0011869) | 3.16708907 |
| 27 | Impaired platelet aggregation (HP:0003540) | 3.16708907 |
| 28 | Increased cerebral lipofuscin (HP:0011813) | 3.15928369 |
| 29 | Distal lower limb amyotrophy (HP:0008944) | 3.14260858 |
| 30 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.04821298 |
| 31 | Progressive muscle weakness (HP:0003323) | 3.00378694 |
| 32 | High pitched voice (HP:0001620) | 2.98613435 |
| 33 | Distal lower limb muscle weakness (HP:0009053) | 2.96772153 |
| 34 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.95050350 |
| 35 | Amyloidosis (HP:0011034) | 2.89070550 |
| 36 | Poor head control (HP:0002421) | 2.86786430 |
| 37 | Cerebral inclusion bodies (HP:0100314) | 2.86786048 |
| 38 | IgM deficiency (HP:0002850) | 2.86571048 |
| 39 | Hyperacusis (HP:0010780) | 2.84991520 |
| 40 | Nonprogressive disorder (HP:0003680) | 2.82258734 |
| 41 | Petechiae (HP:0000967) | 2.82096652 |
| 42 | Chronic otitis media (HP:0000389) | 2.82085965 |
| 43 | Abolished electroretinogram (ERG) (HP:0000550) | 2.76962606 |
| 44 | Recurrent fungal infections (HP:0002841) | 2.76568682 |
| 45 | Spondylolisthesis (HP:0003302) | 2.72982218 |
| 46 | Achilles tendon contracture (HP:0001771) | 2.72839916 |
| 47 | Stomatitis (HP:0010280) | 2.72701186 |
| 48 | Abnormal gallbladder physiology (HP:0012438) | 2.67623928 |
| 49 | Cholecystitis (HP:0001082) | 2.67623928 |
| 50 | Abnormality of the fingertips (HP:0001211) | 2.67529826 |
| 51 | Myocardial infarction (HP:0001658) | 2.65487721 |
| 52 | Apathy (HP:0000741) | 2.60792988 |
| 53 | Poikiloderma (HP:0001029) | 2.59205320 |
| 54 | J-shaped sella turcica (HP:0002680) | 2.58115491 |
| 55 | Attenuation of retinal blood vessels (HP:0007843) | 2.55967966 |
| 56 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.54986837 |
| 57 | Increased connective tissue (HP:0009025) | 2.54706590 |
| 58 | Short nail (HP:0001799) | 2.54586985 |
| 59 | Abnormality of macrophages (HP:0004311) | 2.54515182 |
| 60 | Periodontitis (HP:0000704) | 2.53745090 |
| 61 | Supranuclear gaze palsy (HP:0000605) | 2.52694487 |
| 62 | Aortic aneurysm (HP:0004942) | 2.52552101 |
| 63 | Recurrent viral infections (HP:0004429) | 2.52187608 |
| 64 | Mediastinal lymphadenopathy (HP:0100721) | 2.51475659 |
| 65 | Hypokinesia (HP:0002375) | 2.51145058 |
| 66 | Obstructive lung disease (HP:0006536) | 2.51008627 |
| 67 | Chronic obstructive pulmonary disease (HP:0006510) | 2.51008627 |
| 68 | Deep venous thrombosis (HP:0002625) | 2.45347254 |
| 69 | Distal upper limb amyotrophy (HP:0007149) | 2.45182355 |
| 70 | Upper limb amyotrophy (HP:0009129) | 2.45182355 |
| 71 | Macular degeneration (HP:0000608) | 2.44564829 |
| 72 | Diminished motivation (HP:0000745) | 2.43442788 |
| 73 | Abnormality of the Achilles tendon (HP:0005109) | 2.43243096 |
| 74 | Restrictive lung disease (HP:0002091) | 2.42809725 |
| 75 | Weak cry (HP:0001612) | 2.42736854 |
| 76 | Recurrent skin infections (HP:0001581) | 2.42201562 |
| 77 | Ragged-red muscle fibers (HP:0003200) | 2.41017627 |
| 78 | Pustule (HP:0200039) | 2.38943340 |
| 79 | Gingivitis (HP:0000230) | 2.38775229 |
| 80 | Trismus (HP:0000211) | 2.38559219 |
| 81 | Neuronal loss in central nervous system (HP:0002529) | 2.35098330 |
| 82 | Abnormality of macular pigmentation (HP:0008002) | 2.34793939 |
| 83 | Upper motor neuron abnormality (HP:0002127) | 2.33733224 |
| 84 | Dyschromatopsia (HP:0007641) | 2.33325311 |
| 85 | Osteomyelitis (HP:0002754) | 2.31195361 |
| 86 | Insomnia (HP:0100785) | 2.30720909 |
| 87 | Upper limb muscle weakness (HP:0003484) | 2.29902769 |
| 88 | Meningitis (HP:0001287) | 2.28274833 |
| 89 | Photophobia (HP:0000613) | 2.25646329 |
| 90 | Difficulty climbing stairs (HP:0003551) | 2.23142393 |
| 91 | Broad face (HP:0000283) | 2.23080222 |
| 92 | Increased serum ferritin (HP:0003281) | 2.23061837 |
| 93 | Rough bone trabeculation (HP:0100670) | 2.22289388 |
| 94 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.22070686 |
| 95 | Disinhibition (HP:0000734) | 2.21998636 |
| 96 | Generalized amyotrophy (HP:0003700) | 2.21161849 |
| 97 | Thyroiditis (HP:0100646) | 2.20971977 |
| 98 | Aplastic anemia (HP:0001915) | 2.16865652 |
| 99 | Chest pain (HP:0100749) | 2.16030778 |
| 100 | Constricted visual fields (HP:0001133) | 2.15254403 |
| 101 | Inflammation of the large intestine (HP:0002037) | 2.13970303 |
| 102 | Prolonged bleeding time (HP:0003010) | 2.13872362 |
| 103 | Lymphopenia (HP:0001888) | 2.13713885 |
| 104 | Osteolytic defects of the hand bones (HP:0009699) | 2.13700404 |
| 105 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.13700404 |
| 106 | Prolonged neonatal jaundice (HP:0006579) | 2.12665188 |
| 107 | Gastrointestinal inflammation (HP:0004386) | 2.10958570 |
| 108 | Abnormal trabecular bone morphology (HP:0100671) | 2.10000800 |
| 109 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.09781219 |
| 110 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.09781219 |
| 111 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.09781219 |
| 112 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.09218819 |
| 113 | Leukocytosis (HP:0001974) | 2.07280147 |
| 114 | Epistaxis (HP:0000421) | 2.06269484 |
| 115 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.05228760 |
| 116 | Increased IgE level (HP:0003212) | 2.04633453 |
| 117 | Nail dystrophy (HP:0008404) | 2.04623830 |
| 118 | Aplasia cutis congenita (HP:0001057) | 2.04475583 |
| 119 | Type II diabetes mellitus (HP:0005978) | 2.04220405 |
| 120 | Hemorrhage of the eye (HP:0011885) | 2.04090137 |
| 121 | Colitis (HP:0002583) | 2.03859262 |
| 122 | Agnosia (HP:0010524) | 2.03588939 |
| 123 | Progressive neurologic deterioration (HP:0002344) | 2.03442998 |
| 124 | Lower limb amyotrophy (HP:0007210) | 2.03203711 |
| 125 | Decreased central vision (HP:0007663) | 2.03082637 |
| 126 | Fatigue (HP:0012378) | 2.01500880 |
| 127 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.00905973 |
| 128 | Reticulocytopenia (HP:0001896) | 1.99897015 |
| 129 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.99675465 |
| 130 | Hepatosplenomegaly (HP:0001433) | 1.99039658 |
| 131 | Severe visual impairment (HP:0001141) | 1.98689513 |
| 132 | Orchitis (HP:0100796) | 1.98274534 |
| 133 | Diaphragmatic weakness (HP:0009113) | 1.98210873 |
| 134 | Pulmonary infiltrates (HP:0002113) | 1.97376940 |
| 135 | Papilledema (HP:0001085) | 1.96651773 |
| 136 | Glucose intolerance (HP:0000833) | 1.95430968 |
| 137 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.94546797 |
| 138 | Mucopolysacchariduria (HP:0008155) | 1.94546797 |
| 139 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.94335231 |
| 140 | Polygenic inheritance (HP:0010982) | 1.93331209 |
| 141 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.93100976 |
| 142 | Recurrent bronchitis (HP:0002837) | 1.92537181 |
| 143 | Volvulus (HP:0002580) | 1.92450894 |
| 144 | Natal tooth (HP:0000695) | 1.92149681 |
| 145 | Urticaria (HP:0001025) | 1.91926387 |
| 146 | Increased density of long bones (HP:0006392) | 1.91016637 |
| 147 | Nasal polyposis (HP:0100582) | 1.90719605 |
| 148 | Dysostosis multiplex (HP:0000943) | 1.90152782 |
| 149 | Arterial thrombosis (HP:0004420) | 1.90107882 |
| 150 | Pallor (HP:0000980) | 1.89897646 |
| 151 | Abnormality of the nasal mucosa (HP:0000433) | 1.89624526 |
| 152 | Spontaneous hematomas (HP:0007420) | 1.89211268 |
| 153 | Progressive visual loss (HP:0000529) | 1.88836768 |
| 154 | Central scotoma (HP:0000603) | 1.88268513 |
| 155 | Acute lymphatic leukemia (HP:0006721) | 1.87897909 |
| 156 | Vasculitis (HP:0002633) | 1.86869952 |
| 157 | Personality changes (HP:0000751) | 1.86532672 |
| 158 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.86205042 |
| 159 | Gingival bleeding (HP:0000225) | 1.85725851 |
| 160 | Acute myeloid leukemia (HP:0004808) | 1.85410413 |
| 161 | Emphysema (HP:0002097) | 1.84365805 |
| 162 | Systemic lupus erythematosus (HP:0002725) | 1.82952510 |
| 163 | Abnormality of the prostate (HP:0008775) | 1.82796969 |
| 164 | Bone pain (HP:0002653) | 1.82791451 |
| 165 | Thoracic kyphosis (HP:0002942) | 1.82553724 |
| 166 | Hypergammaglobulinemia (HP:0010702) | 1.79819065 |
| 167 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.78799780 |
| 168 | Sparse eyelashes (HP:0000653) | 1.78040171 |
| 169 | Scotoma (HP:0000575) | 1.77020619 |
| 170 | Vascular calcification (HP:0004934) | 1.76585493 |
| 171 | Premature rupture of membranes (HP:0001788) | 1.75870909 |
| 172 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.75799158 |
| 173 | Ureteral duplication (HP:0000073) | 1.74071129 |
| 174 | Abnormality of glycolysis (HP:0004366) | 1.73555776 |
| 175 | Right ventricular cardiomyopathy (HP:0011663) | 1.73093489 |
| 176 | Purpura (HP:0000979) | 1.71498012 |
| 177 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.70958269 |
| 178 | Hand muscle atrophy (HP:0009130) | 1.69525983 |
| 179 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.69509937 |
| 180 | Ureteral stenosis (HP:0000071) | 1.69489819 |
| 181 | Pathologic fracture (HP:0002756) | 1.68361209 |
| 182 | Entropion (HP:0000621) | 1.66587875 |
| 183 | Plantar hyperkeratosis (HP:0007556) | 1.66543027 |
| 184 | Hyperparathyroidism (HP:0000843) | 1.64602187 |
| 185 | Deviation of the thumb (HP:0009603) | 1.62194491 |
| 186 | Cardiomegaly (HP:0001640) | 1.61914568 |
| 187 | Dementia (HP:0000726) | 1.60902587 |
| 188 | Abnormal blistering of the skin (HP:0008066) | 1.60228635 |
| 189 | Onycholysis (HP:0001806) | 1.59768054 |
| 190 | Multiple lipomas (HP:0001012) | 1.59618641 |
| 191 | Elbow flexion contracture (HP:0002987) | 1.58789820 |
| 192 | Focal segmental glomerulosclerosis (HP:0000097) | 1.58771582 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA2 | 5.30800108 |
| 2 | MAP3K4 | 4.39316054 |
| 3 | MST1R | 4.07011545 |
| 4 | MAP2K7 | 4.05382342 |
| 5 | TAOK2 | 3.66124809 |
| 6 | EEF2K | 3.13734782 |
| 7 | MAP4K1 | 2.97447117 |
| 8 | PKN2 | 2.66914030 |
| 9 | LMTK2 | 2.47216988 |
| 10 | CAMK1D | 2.46017867 |
| 11 | CDK3 | 2.41589882 |
| 12 | KIT | 2.38105233 |
| 13 | TESK2 | 2.25318046 |
| 14 | PIM2 | 2.24129562 |
| 15 | BTK | 2.19275304 |
| 16 | TESK1 | 2.13857187 |
| 17 | CAMK1G | 2.10761286 |
| 18 | MAP2K4 | 2.01827943 |
| 19 | ICK | 1.95196631 |
| 20 | PRPF4B | 1.82528511 |
| 21 | JAK3 | 1.80051839 |
| 22 | RPS6KB2 | 1.78897151 |
| 23 | TYK2 | 1.77961478 |
| 24 | ARAF | 1.77652207 |
| 25 | CSF1R | 1.73423719 |
| 26 | TBK1 | 1.67537977 |
| 27 | BLK | 1.67305923 |
| 28 | SIK1 | 1.60512002 |
| 29 | ERN1 | 1.59821867 |
| 30 | WNK3 | 1.58572706 |
| 31 | SYK | 1.57572004 |
| 32 | FLT3 | 1.54996920 |
| 33 | NME2 | 1.54072519 |
| 34 | CAMKK2 | 1.53481235 |
| 35 | MET | 1.53141863 |
| 36 | ABL2 | 1.52013020 |
| 37 | RET | 1.50248672 |
| 38 | SMG1 | 1.49133526 |
| 39 | ZAP70 | 1.48144374 |
| 40 | PTK6 | 1.47876549 |
| 41 | TAOK3 | 1.43747627 |
| 42 | MOS | 1.41730013 |
| 43 | CDK12 | 1.40517850 |
| 44 | MAP3K10 | 1.38781767 |
| 45 | FES | 1.34798261 |
| 46 | TRIB3 | 1.31780009 |
| 47 | HCK | 1.30770279 |
| 48 | MUSK | 1.23977445 |
| 49 | LIMK1 | 1.21252757 |
| 50 | IKBKE | 1.21225943 |
| 51 | BUB1 | 1.20950461 |
| 52 | TGFBR2 | 1.20747817 |
| 53 | IRAK4 | 1.19570730 |
| 54 | MAP2K3 | 1.17382055 |
| 55 | STK16 | 1.16335421 |
| 56 | MAP3K14 | 1.14958451 |
| 57 | TEC | 1.12724585 |
| 58 | IKBKB | 1.11139190 |
| 59 | VRK2 | 1.10379087 |
| 60 | ITK | 1.07567206 |
| 61 | LRRK2 | 1.04631473 |
| 62 | GRK7 | 1.04579834 |
| 63 | STK10 | 1.03673882 |
| 64 | LATS2 | 1.02818309 |
| 65 | NEK2 | 1.00728127 |
| 66 | TXK | 1.00722330 |
| 67 | DDR2 | 1.00439841 |
| 68 | PIM1 | 0.97452037 |
| 69 | RPS6KA4 | 0.96573888 |
| 70 | GRK1 | 0.96487343 |
| 71 | ALK | 0.95931580 |
| 72 | PTK2 | 0.94574463 |
| 73 | MAP3K1 | 0.91290129 |
| 74 | TRPM7 | 0.90027531 |
| 75 | LCK | 0.88853566 |
| 76 | PBK | 0.88383187 |
| 77 | MKNK2 | 0.88136704 |
| 78 | ERBB4 | 0.87179081 |
| 79 | MELK | 0.82470196 |
| 80 | LYN | 0.82080213 |
| 81 | IRAK3 | 0.81561017 |
| 82 | JAK1 | 0.81280183 |
| 83 | DAPK1 | 0.80420882 |
| 84 | MAPK4 | 0.79174456 |
| 85 | CDK4 | 0.77556819 |
| 86 | HIPK2 | 0.76848475 |
| 87 | PAK4 | 0.76444034 |
| 88 | IRAK2 | 0.75612442 |
| 89 | MAP3K8 | 0.74443163 |
| 90 | JAK2 | 0.73817542 |
| 91 | CDK8 | 0.73660235 |
| 92 | ATR | 0.70049678 |
| 93 | EPHB1 | 0.69497775 |
| 94 | CAMKK1 | 0.68938219 |
| 95 | SCYL2 | 0.66434011 |
| 96 | PRKG2 | 0.64291443 |
| 97 | CDC7 | 0.60154971 |
| 98 | MAPKAPK3 | 0.59078273 |
| 99 | BRAF | 0.58267437 |
| 100 | CDK6 | 0.57705011 |
| 101 | CHUK | 0.57074788 |
| 102 | GRK6 | 0.56115841 |
| 103 | CDK9 | 0.55002386 |
| 104 | PDGFRA | 0.54084610 |
| 105 | PHKG2 | 0.53983555 |
| 106 | PHKG1 | 0.53983555 |
| 107 | SIK2 | 0.53774578 |
| 108 | NEK1 | 0.51647019 |
| 109 | MATK | 0.50958611 |
| 110 | CSK | 0.50719606 |
| 111 | BRSK1 | 0.50631893 |
| 112 | AURKA | 0.50382919 |
| 113 | FGFR3 | 0.50129769 |
| 114 | MAP3K5 | 0.49101968 |
| 115 | MAP3K9 | 0.48784019 |
| 116 | EIF2AK3 | 0.48381315 |
| 117 | BRD4 | 0.48338876 |
| 118 | MAP3K11 | 0.48013031 |
| 119 | TTN | 0.45279120 |
| 120 | PDK1 | 0.45140761 |
| 121 | CAMK1 | 0.45080369 |
| 122 | RPS6KA2 | 0.44573596 |
| 123 | MAPKAPK2 | 0.43982169 |
| 124 | MTOR | 0.43761289 |
| 125 | MAP3K7 | 0.43663362 |
| 126 | CSNK1A1L | 0.41837770 |
| 127 | MAPK11 | 0.41748938 |
| 128 | CDC42BPA | 0.41647725 |
| 129 | TGFBR1 | 0.41624845 |
| 130 | MAP3K3 | 0.40072304 |
| 131 | MKNK1 | 0.38455108 |
| 132 | PAK1 | 0.37256739 |
| 133 | EGFR | 0.37253456 |
| 134 | CDK7 | 0.37072998 |
| 135 | EIF2AK2 | 0.36756893 |
| 136 | ABL1 | 0.36350317 |
| 137 | FGFR4 | 0.35296472 |
| 138 | EIF2AK1 | 0.34374863 |
| 139 | PASK | 0.33837174 |
| 140 | RPS6KA6 | 0.33650449 |
| 141 | TAOK1 | 0.33570602 |
| 142 | PRKCI | 0.33306688 |
| 143 | RPS6KB1 | 0.33281721 |
| 144 | RIPK1 | 0.33090232 |
| 145 | MAP3K13 | 0.32737964 |
| 146 | BMX | 0.32681915 |
| 147 | RIPK4 | 0.32575891 |
| 148 | SIK3 | 0.30520116 |
| 149 | GSK3A | 0.29937425 |
| 150 | CDK11A | 0.27310446 |
| 151 | CDK15 | 0.26205266 |
| 152 | CHEK2 | 0.25380310 |
| 153 | CAMK2G | 0.25185137 |
| 154 | SRPK1 | 0.23822845 |
| 155 | PDK2 | 0.23656675 |
| 156 | CDK14 | 0.23510030 |
| 157 | FGR | 0.23252037 |
| 158 | CDK18 | 0.23119279 |
| 159 | DAPK3 | 0.22921210 |
| 160 | PDPK1 | 0.20194101 |
| 161 | CCNB1 | 0.20055163 |
| 162 | NTRK1 | 0.19812755 |
| 163 | MAP2K6 | 0.16976177 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 4.65426030 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.42510939 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.40874823 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.26130629 |
| 5 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.22193777 |
| 6 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.11441746 |
| 7 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.04049169 |
| 8 | Galactose metabolism_Homo sapiens_hsa00052 | 2.03788816 |
| 9 | DNA replication_Homo sapiens_hsa03030 | 2.02401120 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.97026597 |
| 11 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.95155001 |
| 12 | Bladder cancer_Homo sapiens_hsa05219 | 1.94699792 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.94601874 |
| 14 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.87694755 |
| 15 | Pertussis_Homo sapiens_hsa05133 | 1.74234838 |
| 16 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.72739470 |
| 17 | Other glycan degradation_Homo sapiens_hsa00511 | 1.68850073 |
| 18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.67940386 |
| 19 | Proteasome_Homo sapiens_hsa03050 | 1.67688815 |
| 20 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.66463995 |
| 21 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.60238282 |
| 22 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.59478307 |
| 23 | Hepatitis B_Homo sapiens_hsa05161 | 1.55936815 |
| 24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.53021826 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.52109828 |
| 26 | Apoptosis_Homo sapiens_hsa04210 | 1.50466022 |
| 27 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.49417585 |
| 28 | Shigellosis_Homo sapiens_hsa05131 | 1.46885171 |
| 29 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.46752129 |
| 30 | Sulfur relay system_Homo sapiens_hsa04122 | 1.46176074 |
| 31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.45122101 |
| 32 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.44933725 |
| 33 | Mismatch repair_Homo sapiens_hsa03430 | 1.43529508 |
| 34 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.43097412 |
| 35 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.42933529 |
| 36 | Prion diseases_Homo sapiens_hsa05020 | 1.42724197 |
| 37 | Measles_Homo sapiens_hsa05162 | 1.42488700 |
| 38 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.42406342 |
| 39 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.40086932 |
| 40 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.39242138 |
| 41 | Tuberculosis_Homo sapiens_hsa05152 | 1.37013578 |
| 42 | Influenza A_Homo sapiens_hsa05164 | 1.34493436 |
| 43 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.33960201 |
| 44 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.33636770 |
| 45 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.31458318 |
| 46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.28925643 |
| 47 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.27702916 |
| 48 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.26727913 |
| 49 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.24786657 |
| 50 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.21849181 |
| 51 | Salmonella infection_Homo sapiens_hsa05132 | 1.19870164 |
| 52 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.17490964 |
| 53 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.16414674 |
| 54 | Platelet activation_Homo sapiens_hsa04611 | 1.13021055 |
| 55 | Colorectal cancer_Homo sapiens_hsa05210 | 1.11979403 |
| 56 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.10360002 |
| 57 | Malaria_Homo sapiens_hsa05144 | 1.09673927 |
| 58 | Legionellosis_Homo sapiens_hsa05134 | 1.08215376 |
| 59 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.08177163 |
| 60 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.07155238 |
| 61 | Carbon metabolism_Homo sapiens_hsa01200 | 1.06367514 |
| 62 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.06219523 |
| 63 | Lysosome_Homo sapiens_hsa04142 | 1.03361498 |
| 64 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.03147830 |
| 65 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.02565337 |
| 66 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.02555005 |
| 67 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.01637800 |
| 68 | Ribosome_Homo sapiens_hsa03010 | 1.00698713 |
| 69 | Asthma_Homo sapiens_hsa05310 | 0.96464214 |
| 70 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.96023467 |
| 71 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.95603619 |
| 72 | Base excision repair_Homo sapiens_hsa03410 | 0.95091503 |
| 73 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.92138687 |
| 74 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.89538908 |
| 75 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.87739032 |
| 76 | HTLV-I infection_Homo sapiens_hsa05166 | 0.86975308 |
| 77 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.86093610 |
| 78 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.84702239 |
| 79 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.84043909 |
| 80 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.83714111 |
| 81 | Cell cycle_Homo sapiens_hsa04110 | 0.83444555 |
| 82 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.82379254 |
| 83 | Hepatitis C_Homo sapiens_hsa05160 | 0.81264506 |
| 84 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.80211642 |
| 85 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.79049745 |
| 86 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.76750570 |
| 87 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.76373037 |
| 88 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.75632909 |
| 89 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.75349041 |
| 90 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.74871122 |
| 91 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.73573358 |
| 92 | Amoebiasis_Homo sapiens_hsa05146 | 0.72562247 |
| 93 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.72507613 |
| 94 | Melanoma_Homo sapiens_hsa05218 | 0.70472118 |
| 95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.69887008 |
| 96 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.69824637 |
| 97 | Viral myocarditis_Homo sapiens_hsa05416 | 0.69641429 |
| 98 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.68710370 |
| 99 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.67440254 |
| 100 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.66547001 |
| 101 | Homologous recombination_Homo sapiens_hsa03440 | 0.66251592 |
| 102 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.65797891 |
| 103 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.65383617 |
| 104 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.64179649 |
| 105 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.64076711 |
| 106 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.63907210 |
| 107 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.63378308 |
| 108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63316916 |
| 109 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.62233534 |
| 110 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.61810392 |
| 111 | Phagosome_Homo sapiens_hsa04145 | 0.60251492 |
| 112 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.59473113 |
| 113 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.57925418 |
| 114 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.56818124 |
| 115 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.56484101 |
| 116 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.56190721 |
| 117 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.55895374 |
| 118 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.55705278 |
| 119 | Allograft rejection_Homo sapiens_hsa05330 | 0.54746514 |
| 120 | Spliceosome_Homo sapiens_hsa03040 | 0.54235292 |
| 121 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.53325758 |
| 122 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.53211995 |
| 123 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.53020374 |
| 124 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.51699071 |
| 125 | Endocytosis_Homo sapiens_hsa04144 | 0.50324372 |
| 126 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.49374301 |
| 127 | Insulin resistance_Homo sapiens_hsa04931 | 0.48930951 |
| 128 | Pathways in cancer_Homo sapiens_hsa05200 | 0.47270886 |
| 129 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46143948 |
| 130 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.45656412 |
| 131 | RNA polymerase_Homo sapiens_hsa03020 | 0.44560595 |
| 132 | Thyroid cancer_Homo sapiens_hsa05216 | 0.43966780 |
| 133 | Basal transcription factors_Homo sapiens_hsa03022 | 0.41707181 |
| 134 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.41654530 |
| 135 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.40434872 |
| 136 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.40432090 |
| 137 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.38331223 |
| 138 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.36603685 |
| 139 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.34756044 |
| 140 | Salivary secretion_Homo sapiens_hsa04970 | 0.34551694 |

